Funding opp: DOCK 2015-16 Pilot & Feasibility Projects
The Duke O’Brien Center for Kidney Research is funding up to three Pilot & Feasibility Projects for the 2015-16 academic year. Apply by by April 30, 2015.
Howard Rockman to direct Duke Cardiovascular Research Center
Howard Rockman, MD, professor of medicine, has agreed to serve as director of the Duke Cardiovascular Research Center. The mission of the CVRC is to solidify, enhance and support outstanding cardiovascular research from the basic discovery end of the translational research spectrum.
Duke research: Investigational therapy could attack cause of sickle cell crises
Marilyn Telen, MD leads small study that finds treatment for painful episodes of blood vessel obstruction in sickle cell anemia is currently limited to controlling pain, but an investigational therapy might be able to interfere with the underlying cause of these events, known as vaso-occlusion crises.
Cynthia Moylan receives 2015 ACG Junior Faculty Development Grant
Cynthia Moylan, MD, MHS, assistant professor of medicine (Gastroenterology) has been awarded one of three 2015 ACG Junior Faculty Development Grants from the American College of Gastroenterology.
Duke awarded $10.4 million contract to continue developing radiation test
The Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S.
Chief Residents for 2016-2017 announced
Mary Klotman, MD, chair of the department, Aimee Zaas, MD, MHS, program director of the Internal Medicine Residency Program, and David Simel, MD, vice chair for Veterans Affairs, have announced the
Boulware named CTSA contact principal investigator
Dean Nancy Andrews, MD, PhD, has announced that L.
Califf appointed deputy commissioner of FDA
Rob Califf, MD, professor of medicine (Cardiology) and vice chancellor for cli
Gierisch appointed associate director of VA Evidence-Based Synthesis Program
Congratulations to Jennifer Gierisch, PhD, assistant professor of medicine, who has been appointed associate director of the
Department welcomes new Duke Center for Applied Genomics & Precision Medicine
The new Duke Center for Applied Genomics & Precision Medicine will build on existing initiatives to promote translational genomics and medicine within the Department of Medicine and across the university.
“The Center for Applied Genomics & Precision Medicine aims to accelerate the application of innovative approaches to disease detection and characterization in order to improve patient outcomes,” said Geoff Ginsburg, MD, PhD, director of the new center.
The placement of the center in the Department of Medicine is strategic and deliberate, he said. It’s meant to catalyze innovation in genomics and medicine and to quicken the pace at which genomic medicine and personalized care is woven into the fabric of the department’s three missions.